Alpelisib (Piqray,Apelidx)

Alpelisib is an oral phosphatidylinositol-3-kinase (PI3K) inhibitor. Its mechanism of action is to block the activity of PI3K enzymes, inhibit the proliferation and spread of tumor cells, and simultaneously induce the apoptosis of breast cancer cells.

50mg*28tablets
150mg*28tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Alpelisib Medication Guide

Alpelisib(Piqray)

Indications：Alpelisib is an oral phosphatidylinositol-3-kinase (PI3K) inhibitor. Its mechanism of acti···

WhatsApp
Official Service

Dificid's Efficacy and Actions

Dificid's Efficacy and ActionsDificid was developed by Astellas Pharma in Japan and approved by the US FDA on May 27, 2011.Dificid is a fermentati···【More】
Update: 18 Mar,2026Source: BigbearViews: 149
Precautions for Apellixis Use

Apellixis is a targeted therapy for a specific type of breast cancer, developed by Novartis in Switzerland and approved by the US FDA in 2019.Precauti···【More】
Update: 18 Mar,2026Source: BigbearViews: 148